| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.0091 | 0.9 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | 0.027 | 0.9 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.008 | 0.9 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |